Skip to content

Effect of transcutaneous auricular vagus nerve stimulation on postoperative sleep quality in patients undergoing laparoscopic gynecological surgery

Effect of transcutaneous auricular vagus nerve stimulation on postoperative sleep quality in patients undergoing laparoscopic gynecological surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600115935
Enrollment
Unknown
Registered
2026-01-04
Start date
2026-01-08
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative sleep disturbance

Interventions

Sponsors

Ningbo Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Age between 18 and 65 years; 2.American Society of Anesthesiologists (ASA) physical status classification I-II; 3.Preoperative Pittsburgh Sleep Quality Index (PSQI) score =1 hour (from skin incision to wound closure; surgical procedures limited to laparoscopic hysterectomy or laparoscopic oophorectomy); 5.Capacity to provide informed consent voluntarily, with the ability to comprehend and cooperate with the study protocol.

Exclusion criteria

Exclusion criteria: 1.Patients declined to participate in this study; 2.Comorbid severe systemic diseases, substantial functional impairment, or one or more moderate-to-severe conditions: poorly controlled diabetes (including fasting blood glucose >=7.0 mmol/L, 2-hour postprandial blood glucose >=10.0 mmol/L, or glycated hemoglobin (HbA1c) >=7%) or hypertension (systolic blood pressure >=140 mmHg or diastolic blood pressure >=90 mmHg), chronic obstructive pulmonary disease, active hepatitis, pacemaker implantation, reduced left ventricular ejection fraction, end-stage renal disease requiring regular dialysis, history of myocardial infarction, cerebrovascular accident, transient ischemic attack, or coronary artery disease/coronary stent implantation (with onset >3 months prior); 3.Body mass index (BMI) >=28 kg/m^2; 4.History of substance abuse (long-term use of morphine >=30 mg/day or equivalent); 5.History of alcohol abuse (long-term alcohol consumption >7 standard drinks/week for females, with one standard drink defined as 10 g of pure alcohol); 6.Use of sedative-hypnotic medications within one month prior to surgery; 7.Vulnerable populations (patients with hearing impairment, visual impairment, dementia, psychiatric disorders, or those using psychotropic medications).

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative sleep disturbance on postoperative day 3;Quality of Postoperative Recovery;

Secondary

MeasureTime frame
Incidence of postoperative sleep disturbance on postoperative day 1 and 2;Anxiety/Depression Levels;Postoperative Pain;Complications;

Countries

China

Contacts

Public ContactWang Fang

Ningbo No.2 hospital

andrae90@outlook.com+86 187 5842 3102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026